Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||tumor infiltrating lymphocytes|
Tumor infiltrating lymphocytes (TIL) are used as a type of adoptive cell therapy, where TILs are isolated from patients, expanded, and then reintroduced, potentially resulting in decreased tumor growth (PMID: 26578452, PMID: 24329789).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Aldesleukin + Nivolumab + tumor infiltrating lymphocytes||Aldesleukin Nivolumab tumor infiltrating lymphocytes||0||1|
|Pembrolizumab + tumor infiltrating lymphocytes||Pembrolizumab tumor infiltrating lymphocytes||0||0|
|tumor infiltrating lymphocytes||tumor infiltrating lymphocytes||0||2|